RLYP black box warning wonderings
November 03, 2015 at 10:13 AM EST
I don’t see any comments in any of the threads about this, following up Dr. KSS’ writings about RLYP. In late October the Hyperkalemia drug Veltassa was approved for sale in the U.S., but with a caveat. This from the Motley Fool on Oct. 22: ”While FDA approvals usually send a stock soaring higher, investors […]
